Johnson and Johnson pauses coronavirus vaccine trials due to unexplained illness in participantChristian Fernsby ▼ | October 13, 2020
Johnson and Johnson said on Monday it had temporarily paused its coronavirus vaccine candidate clinical trials due to an unexplained illness in a study participant.
Coronavirus vaccine trials Johnson and Johnson
Topics: Johnson and Johnson
"Following our guidelines, the participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board (DSMB) as well as our internal clinical and safety physicians.
"SAEs are not uncommon in clinical trials, and the number of SAEs can reasonably be expected to increase in trials involving large numbers of participants." ■